Luteinising hormone releasing hormone agonist in women with endometriosis

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (4)

• Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data via openalex
• "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis via openalex
• W1999683827 via openalex
• W2395322658 via openalex

Cited by (6)

• Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
• Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group 1990
• Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
• Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile 1990
• GnRH analogues in the treatment of endometriosis 1989
• Treatment of Endometriosis by Nasal Administration of Nafarelin 1987

Source provenance

europepmc

last seen: 2026-10-14T06:08:39.101224+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-10-08T21:58:08.863946+00:00

unpaywall

last seen: 2026-10-14T06:23:58.021457+00:00